Hochschulschrift
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
- Alternative title
-
Effekte von Stammzell-Transkriptionsfaktor exprimierenden Vaccinia Viren in onkolytischer Virotherapie
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Würzburg, Universität Würzburg, Dissertation, 2012
- Keyword
-
Lungenkrebs
Darmkrebs
Vaccinia-Virus
Transkriptionsfaktor
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2012
- Creator
- Contributor
-
Szalay, Aladar A.
- URN
-
urn:nbn:de:bvb:20-opus-85139
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:41 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Ehrig, Klaas
- Szalay, Aladar A.
- Universität Würzburg
Time of origin
- 2012
Other Objects (12)
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
Combinational therapy of tumors in syngeneic mouse tumor models with oncolytic Vaccinia virus strains expressing IL-2 and INF-g. Human adipose tissue-derived stem cell mediated delivery of oncolytic Vaccinia virus
Combined application of oncolytic vaccinia and measles vaccine viruses for the treatment of highly resistant human tumor cells
Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
Combinational therapy of tumors in syngeneic mouse tumor models with oncolytic Vaccinia virus strains expressing IL-2 and INF-g. Human adipose tissue-derived stem cell mediated delivery of oncolytic Vaccinia virus
Combined application of oncolytic vaccinia and measles vaccine viruses for the treatment of highly resistant human tumor cells
Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
Combinational therapy of tumors in syngeneic mouse tumor models with oncolytic Vaccinia virus strains expressing IL-2 and INF-g. Human adipose tissue-derived stem cell mediated delivery of oncolytic Vaccinia virus
Combined application of oncolytic vaccinia and measles vaccine viruses for the treatment of highly resistant human tumor cells
Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy